Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Salesforce Inc (CRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Salesforce Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $26.37 (market cap $4.70B), while Salesforce Inc trades at $236.5 (market cap $195.81B). The key difference: Salesforce Inc is far larger — about 41.7× ACADIA Pharmaceuticals Inc.'s market cap, and Salesforce Inc pays a 0.74% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold ACADIA Pharmaceuticals Inc. for 77 Days and Salesforce Inc for 88 Days on average.
| ACAD | CRM | |
|---|---|---|
Market Cap | $4.70B | $195.81B |
Volume | 5,482,812 | 21,529,713 |
Sector | Health | Technology |
52-Week High | $30.57 | $266.23 |
52-Week Low | $20.06 | $150.12 |
Typical Hold Time | 77 Days | 88 Days |
Enterprise Value | $3.82B | $226.15B |
Dividend Yield | — | 0.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACADIA Pharmaceuticals (ACAD) trades at $26.36, down 3.41% over 24 hours, amid a bearish technical signal. The company reported strong Q2 2026 earnings, beating estimates with $0.18 EPS, and raised its 2026 revenue outlook. Recent European Commission approval for DAYBU in Rett syndrome expands its market reach. Revenue has grown from $517 million in 2022 to $1.07 billion in 2025, with net income turning positive to $391 million.
The outlook is mixed: strong fundamentals and analyst optimism (70% buy ratings, $33.83 consensus target) support upside, but technical weakness and high valuation multiples (EV/EBITDA 38.82) pose risks. Key catalysts include continued commercial execution and upcoming Alzheimer's data, while investment risks involve competitive pressures and reliance on key drug sales.
Salesforce (CRM) trades at $237.63, down slightly by 0.12% today, with a bullish technical signal from moving averages but neutral oscillators. The company shows strong fundamentals with revenue growth from $37.90B in 2025 to $43.90B projected in 2026, net income margin improving to 21.99%, and consistent earnings beats. Recent news highlights AI-driven growth potential amid sector volatility.
Outlook remains positive with a consensus price target of $271.91, implying 14% upside, supported by 76.53% analyst buy ratings. Risks include competitive pressures in AI software and macroeconomic sensitivity, but robust cash flow and strategic positioning offer resilience for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →
